Immune modulation
Showing 51 - 75 of >10,000
Ischemia Reperfusion Injury, Ischaemia Reperfusion Injury Trial in Aarhus N (Single Cuff Tourniquet 8000)
Completed
- Ischemia Reperfusion Injury
- Ischaemia Reperfusion Injury
- Single Cuff Tourniquet 8000
-
Aarhus N, DenmarkC-Laboratorium, Skejby Sygehus
Mar 20, 2019
Chronic Back Pain Trial in Nahariyya (NaCl 0.9% (normal saline), Magnetized Normal Saline)
Recruiting
- Chronic Back Pain
- NaCl 0.9% (normal saline)
- Magnetized Normal Saline
-
Nahariyya, IsraelGalilee Medical center
Aug 15, 2023
Melanoma Trial in Rochester (GM-CSF, Standard of Care)
Completed
- Melanoma
- GM-CSF
- Standard of Care
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 29, 2020
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid
Not yet recruiting
- TIA
- +2 more
- Interleukin-2 [IL-2]
- Standard care - Carotid Endarterectomy
-
Cambridge, Cambridgeshire, United KingdomAddenbrookes Hospital
Aug 2, 2023
Bladder Cancer Trial in Tampa (Bacille Calmette-Guerrin (BCG), Lenalidomide)
Completed
- Bladder Cancer
- Bacille Calmette-Guerrin (BCG)
- Lenalidomide
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 5, 2019
Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)
Recruiting
- Diffuse Large B Cell Lymphoma
- Itacitinib
- Chimeric antigen receptor (CAR) T-cell therapy
-
Tampa, FloridaMoffitt Cancer Center
Mar 6, 2023
NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma Trial in Montréal (Camu Camu Capsules (Camu Camu powder encapsulated
Recruiting
- NSCLC Stage IV
- +3 more
- Camu Camu Capsules (Camu Camu powder encapsulated (500mg each) + ICI
-
Montréal, Quebec, CanadaCentre hospitalier de l'Université de Montréal (CHUM)
Jul 18, 2022
Sleep Trial in Graz (Omnibiotic Stress Repair, Placebo)
Not yet recruiting
- Sleep
- Omnibiotic Stress Repair
- Placebo
-
Graz, AustriaMedical University Graz
Apr 18, 2023
Fasting Trial in Sacramento (Dietary Fasting)
Recruiting
- Fasting
- Dietary Fasting
-
Sacramento, CaliforniaUC Davis
May 10, 2022
Lung Cancer Stage IV Trial in Maastricht (Radiation)
Not yet recruiting
- Lung Cancer Stage IV
- Radiation
-
Maastricht, NetherlandsMaastricht Radiation Oncology (Maastro)
Aug 29, 2023
Immune Related Adverse Events, Colitis, Hepatitis Trial in Freiburg (ECP)
Recruiting
- Immune Related Adverse Events
- +3 more
-
Freiburg, Baden-Württemberg, GermanyMedical Center - University of Freiburg Albert-Ludwigs-Universit
Jun 9, 2022
From Environmental Contaminants and Maternal/Child Health
Recruiting
- Cancer
- Health Questionnaires
- Specimen sample collection
-
Fresno, California
- +1 more
Feb 17, 2023
Disbiosis Trial in Latina (Probiotic Bifidobacterium Bifidum PRL2010, Control group)
Completed
- Disbiosis
- Probiotic Bifidobacterium Bifidum PRL2010
- Control group
-
Latina, ItalyNeonatology and Neonatal Intensive Care Unit of Santa Maria Gore
Jul 6, 2023
Inflammatory Response Trial in Columbia (Fucoidan 500mg, Placebo)
Completed
- Inflammatory Response
- Fucoidan 500mg
- Placebo
-
Columbia, South CarolinaUniversity of South Carolina Sport Science Lab
Jul 8, 2022
Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)
Recruiting
- Lymphoma
- +3 more
- Isatuximab
- Standard Procedures
-
New York, New YorkColumbia University
Apr 27, 2022
Triple Negative Breast Cancer Trial in New York (Merck 3475 Pembrolizumab, Intraoperative radiation therapy (IORT))
Recruiting
- Triple Negative Breast Cancer
- Merck 3475 Pembrolizumab
- Intraoperative radiation therapy (IORT)
-
New York, New YorkColumbia University Irving Medical Center
Oct 10, 2022
Bone Marrow From Healthy Volunteers and Production of Clinical
Completed
- Bone Marrow Stromal Cells
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 4, 2023
HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer Trial in Seattle
Recruiting
- HER2 Negative Breast Carcinoma
- +6 more
- CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 18, 2022
NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)
Recruiting
- Non-small Cell Lung Cancer
- Nutritional intervention
- Immunotherapy
-
Rotterdam, NetherlandsErasmus MC
Jun 5, 2023
HIV Trial in San Diego, Aurora, Indianapolis (Indinavir sulfate, Lamivudine/Zidovudine, Hepatitis A Vaccine (Inactivated))
Completed
- HIV Infections
- Indinavir sulfate
- +6 more
-
San Diego, California
- +2 more
Oct 27, 2021
Respiratory Infection (for Example, Pneumonia, Bronchitis) Trial in Cheras (Probiotic, Placebo)
Not yet recruiting
- Respiratory Infection (for Example, Pneumonia, Bronchitis)
- Probiotic
- Placebo
-
Cheras, Kuala Lumpur, MalaysiaUKM Medical Centre
Apr 2, 2023
Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial (Stem Cell Educator-Treated Mononuclear Cells Apheresis)
Not yet recruiting
- Severe Acute Respiratory Syndrome (SARS) Pneumonia
- Stem Cell Educator-Treated Mononuclear Cells Apheresis
- (no location specified)
Jun 25, 2021
Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Motolimod, Cetuximab, Nivolumab)
Terminated
- Squamous Cell Carcinoma of the Head and Neck
- Motolimod
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Oct 23, 2019